2024 J . Org. Chem., Vol. 64, No. 6, 1999
Paquette et al.
For B: IR (neat, cm-1) 1776, 1704; 1H NMR (300 MHz,
CDCl3) δ 7.68-7.63 (m, 4 H), 7.48-7.29 (m, 11 H), 7.08 (m, 2
H), 6.81 (m, 2 H), 4.57 (d, J ) 14.5 Hz, 1 H), 4.55-4.45 (m, 1
H), 4.13-4.06 (m, 1 H), 3.92 (d, J ) 14.5 Hz, 1 H), 3.94-3.74
(m, 2 H), 3.77 (s, 3 H), 3.64 (d, J ) 17.3 Hz, 1 H), 3.49 (d, J )
17.3 Hz, 1 H), 2.64-2.55 (m, 1 H), 2.22-2.10 (m, 1 H), 1.06 (s,
9 H); 13C NMR (75 MHz, CDCl3) δ 205.3, 169.5, 159.4, 135.6,
133.42, 133.40, 132.6, 129.6, 129.5, 128.2, 127.9, 127.7, 127.64,
127.60, 127.5, 126.2, 114.2, 83.5, 82.1, 66.2, 55.3, 53.8, 45.9,
42.9, 36.1, 28.5, 26.8, 19.2; FAB MS m/z (M+ + 1) calcd 700.19,
obsd 700.33; [R]2D5 -4.2 (c 1.35, CHCl3).
solution of 66 (1.01 g, 1.88 mmol) in THF (40 mL) and pyridine
(10 mL) was cooled to 0 °C, treated with a solution of osmium
tetraoxide (476 mg, 1.88 mmol) in the minimum amount of
pyridine, allowed to warm to room temperature during 4 h,
and concentrated in vacuo (bath temperature <50 °C). The
resulting dark brown foam was taken up in CH2Cl2 (100 mL),
treated with saturated NaHSO3 solution (1 mL), stirred
vigorously overnight, filtered through a pad of Celite, and
extracted repeatedly with CH2Cl2 (8 × 40 mL). The combined
extracts were dried and concentrated. The residual glass was
taken up in CH2Cl2 (50 mL), treated with acetic anhydride (3
mL), pyridine (6 mL), and DMAP (50 mg), stirred overnight,
and concentrated. The product was chromatographed on silica
gel (elution with 30% ethyl acetate in hexanes) to furnish 122
mg of 69 and 472 mg of 70 (48% total).
For 69: IR (neat, cm-1) 1782, 1681; 1H NMR (300 MHz,
CDCl3) δ 7.70-7.64 (m, 4 H), 7.44-7.43 (m, 6 H), 7.20-7.16
(m, 2 H), 6.88-6.84 (m, 2 H), 5.43 (t, J ) 6.4 Hz, 1 H), 5.20 (d,
J ) 6.3 Hz, 1 H), 4.69-4.64 (m, 1 H), 4.53 (d, J ) 14.4 Hz, 1
H), 4.48 (d, J ) 14.4 Hz, 1 H), 3.91-3.83 (m, 2 H), 3.87 (d, J
) 17.3 Hz, 1 H), 3.80 (s, 3 H), 3.57 (d, J ) 17.3 Hz, 1 H), 2.11
(s, 3 H), 2.05 (s, 3 H), 1.07 (s, 9 H); 13C NMR (75 MHz, CDCl3)
δ 202.1, 172.1, 170.5, 169.9, 166.8, 159.5, 135.6, 133.1, 132.9,
130.0, 129.74, 129.72, 127.4, 126.4, 114.3, 97.6, 83.3, 81.9, 73.8,
71.4 62.9, 55.3, 53.0, 46.0, 26.8, 26.7, 20.6, 20.4, 19.2; FAB MS
m/z (M+ + 1) calcd 659.26, obsd 659.28.
Anal. Calcd for C38H41NO5SeSi: C, 65.32; H, 5.91. Found:
C, 65.28; H, 5.91.
A solution of the A/B mixture (8.90 g, 12.8 mmol) in
methanol (350 mL) at 0 °C was treated with finely ground
NaHCO3 (10.0 g), and the resulting slurry was treated drop-
wise with a solution of sodium metaperiodate (8.20 g, 38.5
mmol) in distilled water (20 mL). After being stirred for 12 h,
the reaction mixture was filtered through a Celite pad, and
the filtrate was concentrated to approximately half-volume
prior to being partitioned between saturated NaHCO3 solution
and ethyl acetate. The separated aqueous phase was extracted
with ethyl acetate, and the combined organic layers were dried
and concentrated. Flash chromatography of the residue on
silica gel (elution with 30% ethyl acetate in hexanes) resulted
in the separation of 66 from 67 (5.69 g total, 82%).
1
For 66: IR (neat, cm-1) 1782, 1707, 1612, 1513; H NMR
Compound 70 was subjected directly to peracid oxidation.
(2R,3S,4R,5S)-2-[(ter t-Bu t yld ip h en ylsiloxy)m et h yl]-
3,4-d ih yd r oxy-9-(p-m eth oxyben zyl)-1,6-d ioxa -9-a za sp ir o-
[4.5]d eca n e Dia ceta te (Ester ) (73). A stirred slurry of 69
(300 mg, 4.6 mmol) and finely ground NaHCO3 (150 mg) in
CH2Cl2 (20 mL) was treated with m-CPBA (225 mg of 70%
purity, 2 equiv) and stirred for 20 in prior to dilution with more
CH2Cl2 (10 mL) and NaHSO3 solution (5 mL). The predescribed
workup led to the isolation of 282 mg (92%) of 73 after
chromatography on silica gel (elution with 30% ethyl acetate
in hexanes): white foam; IR (neat, cm-1) 1756, 1695, 1514;
1H NMR (300 MHz, CDCl3) δ 7.68-7.63 (m, 4 H), 7.49-7.33
(m, 6 H), 7.19-7.15 (m, 2 H), 6.89-6.85 (m, 2 H), 5.62 (d, J )
5.2 Hz, 1 H), 5.47 (dd, J ) 5.2, 7.4 Hz, 1 H), 4.69 (d, J ) 14.5
Hz, 1 H), 4.64-4.60 (m, 1 H), 4.25 (d, J ) 14.5 Hz, 1 H), 4.12
(d, J ) 17.8 Hz, 1 H), 3.96 (d, J ) 17.8 Hz, 1 H), 3.92 (dd, J )
11.5, 4.5 Hz, 1 H), 3.84 (dd, J ) 11.4, 4.4 Hz, 1 H), 3.80 (s, 3
H), 2.10 (s, 3 H), 2.06 (s, 3 H), 1.07 (s, 9 H); 13C NMR (75 MHz,
CDCl3) δ 169.9, 169.6, 162.6, 160.5, 159.7, 135.6, 132.98, 132.8,
130.0, 129.8, 127.8, 126.1, 114.4, 104.3, 83.8, 75.0, 70.5, 63.2,
55.3, 49.1, 47.2, 26.7, 20.6, 20.4, 19.2; FAB MS m/z (M+ + 1)
calcd 676.25, obsd 676.34; [R]2D5 +40.2 (c 0.9, CHCl3).
(2R,3R,4S,5S)-2-[(ter t-Bu t yld ip h en ylsiloxy)m et h yl]-
3,4-d ih yd r oxy-9-(p-m eth oxyben zyl)-1,6-d ioxa -9-a za sp ir o-
[4.5]d eca n e Dia ceta te (Ester ) (74). Comparable oxidation
of 70 (122 mg, 1.87 mmol) delivered 107 mg (86%) of 74 as a
white foam: 1H NMR (300 MHz, CDCl3) δ 77.71-7.60 (m, 4
H), 7.45-7.32 (m, 6 H), 7.25-7.15 (m, 2 H), 6.89-6.83 (m, 2
H), 6.09 (d, J ) 6.3 Hz, 1 H), 5.62 (t, J ) 6.3 Hz, 1 H), 4.67 (d,
J ) 14.6 Hz, 1 H), 4.43 (d, J ) 14.6 Hz, 1 H), 4.32-4.28 (m, 1
H), 4.02 (d, J ) 18.0 Hz, 1 H), 3.84 (d, J ) 18.0 Hz, 1 H), 3.86-
3.78 (m, 2 H), 3.79 (s, 3 H), 2.08 (s, 3 H), 2.07 (s, 3 H), 1.05 (s,
9 H); 13C NMR (75 MHz, CDCl3) δ 169.9, 169.8, 163.3, 160.8,
159.7, 135.7, 132.9, 132.8, 130.0, 129.6, 127.71, 127.68, 126.0,
114.5, 102.4, 83.1, 74.7, 63.8, 55.3, 49.1, 46.9, 26.7, 20.7, 20.4,
19.2; FAB MS m/z (M+ + 1) calcd 676.25, obsd 676.34; [R]2D5
+13.1 (c 1.0 CHCl3).
(300 MHz, CDCl3) δ 7.71-7.25 (m, 10 H), 7.19 (d, J ) 8.6 Hz,
2 H), 6.88 (d, J ) 8.6 Hz, 2 H), 6.37 (dd, J ) 6.1, 4.1 Hz, 1 H),
5.65 (dd, J ) 6.1, 2.1 Hz, 1 H), 5.26 (m, 1 H), 4.59 (d, J ) 14.5
Hz, 1 H), 4.53 (d, J ) 14.5 Hz, 1 H), 4.05 (dd, J ) 10.0, 5.9 Hz,
1 H), 3.83 (dd, J ) 10.0, 7.2 Hz, 1 H), 3.80 (s, 3 H), 3.76 (d, J
) 17.5 Hz, 1 H), 3.65 (d, J ) 17.5 Hz, 1 H), 1.09 (s, 9 H); 13C
NMR (75 MHz, CDCl3) δ 203.7, 168.4. 159.5, 135.54, 135.49,
134.2, 133.4, 133.3, 129.8, 129.6, 127.7, 126.4, 123.8, 114.4,
90.1, 89.8, 67.7, 55.2, 52.7, 46.2, 26.8, 19.2; MS m/z (M+ - 1)
calcd 541.2285, obsd 541.2313; [R]2D5 -102 (c 1.8, CHCl3).
Anal. Calcd for C32H35NO5Si: C, 70.95; H, 6.51. Found: C,
70.83; H, 6.47.
1
For 67: IR (neat, cm-1) 1783, 1703, 1611, 1513; H NMR
(300 MHz, CDCl3) δ 7.69-7.25 (m, 10 H), 7.19 (d, J ) 8.6 Hz,
2 H), 6.88 (d, J ) 8.6 Hz, 2 H), 6.33 (dd, J ) 6.0, 1.5 Hz, 1 H),
5.63 (dd, J ) 6.0, 2.1 Hz, 1 H), 5.38-5.33 (m, 1 H), 4.58 (s, 2
H), 3.92 (dd, J ) 10.2, 5.9 Hz, 1 H), 3.78 (dd, J ) 10.2, 7.0 Hz,
1 H), 3.80 (s, 3 H), 3.71 (d, J ) 17.2 Hz, 1 H), 3.64 (d, J ) 17.2
Hz, 1 H), 1.06 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 202.9,
168.8, 159.6, 135.61, 135.55, 134.0, 133.4, 133.2, 129.9, 129.68,
129.66, 127.7, 126.4, 123.9, 114.4, 90.1, 89.9, 67.5, 55.3, 52.7,
46.3, 26.8, 19.2; MS m/z (M+ - 1) calcd 541.2285, obsd
541.2288; [R]2D5 -12.7 (c 1.8, CHCl3).
(2S,5S)-2-[(ter t-Bu tyldiph en ylsiloxy)m eth yl]-7-(p-m eth -
oxyb en zyl)-9-m et h ylen e-1-oxa -7-a za sp ir o[4.4]n on a n -6-
on e (68). Reaction of 66 (50 mg, 0.093 mmol) with the ylide
prepared from methyltriphenylphosphonium iodide (400 mg)
and n-butyllithium (0.4 mL) in THF (13 mL) according to the
predescribed procedure gave, after chromatography on silica
gel (elution with 40% ethyl acetate in hexanes), 42 mg (84%)
1
of 68 as a colorless oil: IR (neat, cm-1) 1702, 1513; H NMR
(300 MHz, CDCl3) δ 7.71-7.25 (m, 10 H), 7.19 (d, J ) 8.5 Hz,
2 H), 6.88 (d, J ) 8.6 Hz, 2 H), 6.34 (dd, J ) 6.0, 1.5 Hz, 1 H),
5.66 (dd, J ) 6.0, 2.0 Hz, 1 H), 5.34 (m, 1 H), 5.24 (t, J ) 2.3
Hz, 1 H), 5.14-5.08 (m, 1 H), 4.49 (d, J ) 24.5 Hz, 1 H), 4.43
(d, J ) 14.5 Hz, 1 H), 4.07 (dd, J ) 9.7, 5.7 Hz, 1 H), 3.89-
3.72 (m, 3 H), 3.79 (s, 3 H), 1.09 (s, 9 H); 13C NMR (75 MHz,
CDCl3) δ 171.2, 159.2, 142.2, 135.58, 135.56, 133.7, 133.6,
132.0, 129.6, 128.2, 127.8, 127.6, 114.1, 112.8, 91.8, 88.0, 68.5,
55.3, 48.5, 46.4, 27.0, 26.0, 19.3; MS m/z (M+) calcd 541.2648,
obsd 541.2670; [R]2D5 +27.1 (c 2.1, CHCl3).
(2R,3S,4R,5S)-2-[(ter t-Bu t yld ip h en ylsiloxy)m et h yl]-
3,4-d ih yd r oxy-7-(p-m eth oxyben zyl)-1-oxa -7-a za sp ir o[4.4]-
n on an e-6,9-dion e, Diacetate (Ester ) (69) an d (2R,3R,4S,5S)-
2-[(ter t-Bu tyld ip h en ylsiloxy)m eth yl]-3,4-d ih yd r oxy-7-(p-
m et h oxyben zyl)-1-oxa-7-a za sp ir o[4.4]n on a n e-6,9-d ion e,
Dia ceta te (Ester ) (70). P r ototyp ica l P r oced u r e. A stirred
(2R,3S,4R,5R)-2-[(ter t-Bu t yld ip h en ylsiloxy)m et h yl]-
3,4-d ih yd r oxy-7-(p-m eth oxyben zyl)-1-oxa -7-a za sp ir o[4.4]-
n on an e-6,9-dion e,Diacetate (Ester )(71)an d (2R,3R,4S,5R)-
2-[(ter t-Bu tyld ip h en ylsiloxy)m eth yl]-3,4-d ih yd r oxy-7-(p-
m et h oxyben zyl)-1-oxa-7-a za sp ir o[4.4]n on a n e-6,9-d ion e,
Dia ceta te (Ester ) (72). A 1.02 g (1.92 mmol) sample of 67
was osmylated and acetylated in a manner directly paralleling
that described above for 66. There was isolated 132 mg of 71
and 395 mg of 72 (43% total).
For 71: IR (neat, cm-1) 1750, 1697; 1H NMR (300 MHz,
CDCl3) δ 7.67-7.63 (m, 4 H), 7.39-7.26 (m, 6 H), 7.14 (d, J )